58.55 USD
↗ 1.79 (3.15%)AT CLOSE (11:59 AM EDT)
Veracyte, Inc.
VCYTNASDAQ • USD
58.89
↗ 0.34 (0.57%)
POST MARKET (AS OF 06:01 PM EDT)
Post Market
AS OF 06:01 PM EDT
58.89
↗ 0.34 (0.57%)
Market: CLOSED
Veracyte, Inc. (VCYT) is currently trading at $58.52. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, VCYT trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 25, 2026.
Open?$56.96
High?$60.28
Low?$56.82
Prev. Close?$56.76
Volume?1.5M
Avg. Volume?1.3M
VWAP?$58.97
Rel. Volume?1.17x
Bid / Ask
Bid?$49.88 × 100
Ask?$67.03 × 100
Spread?$17.15
Midpoint?$58.46
Valuation & Ratios
Market Cap?4.5B
Shares Out?79.8M
Float?79.3M
Float %?99.4%
P/E Ratio?51.46
P/B Ratio?3.37
EPS?$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Themes
Employees
755
Market Cap
4.5B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2013-10-30
Address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?59
Piotroski F-Score?6/9Mixed
Altman Z-Score?53.39Safe
Confidence?70%Moderate
Short InterestHigh
Short % of Float?10.71%High
Short Interest?8.5M
Days to Cover?6.5
Free Float79.3M
Avg Daily Volume1.3M
Settlement Date2026-06-15
Financial Health
Current Ratio?9.31Strong
Quick Ratio?8.92Strong
Cash Ratio?4.69Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score44/100
P/E?51.5PRICEY▾
Peers100
S&P12
P/B?3.37FAIR▾
Peers100
S&P50
P/S?8.36HIGH▾
Peers100
S&P12
P/FCF?29.2FAIR▾
Peers100
S&P31
EV/EBITDA?35.7HIGH▾
Peers100
S&P8
EV/Sales?7.87HIGH▾
Peers100
S&P17
Returns & Efficiency
ROE?6.6%FAIR▾
Peers50
S&P22
ROA?6.1%FAIR▾
Peers50
S&P54
Cash Flow & Enterprise
FCF?$155.3M
Enterprise Value?$4.3B
Fundamentals ratios updated end of day